SCHEMBL4431771

SCHEMBL4431771

COc1ccc(C(C(C)=O)c2cc(F)ccc2O)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.43
TSHR P16473 2/20 0.43
BLM P54132 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ACHE P22303 2/20 0.41
LMNA P02545 1/20 0.40
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2C9 P11712 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436344 0.82 ALDH1A1 (0.46) NPSR1TSHRBLMALDH1A1HPGD
SCHEMBL8145960 0.73 ACHE (0.46) NPSR1TSHRBLMALDH1A1HPGD
SCHEMBL4432347 0.73 ALDH1A1 (0.50) NPSR1TSHRALDH1A1ACHELMNA
SCHEMBL16973606 0.73 TDP1 (0.51) ALDH1A1ACHELMNAKMT2AMEN1
SCHEMBL8295353 0.72 NR1H4 (0.45) NPSR1TSHRBLMALDH1A1HPGD
SCHEMBL16246442 0.72 TUBB4A (0.46) NPSR1TSHRBLMALDH1A1HPGD
SCHEMBL15540879 0.72 TSHR (0.56) NPSR1TSHRBLMACHECYP3A4
SCHEMBL4434628 0.71 AKR1C3 (0.51) HPGDACHECYP1A2CYP2C19CYP2C9
SCHEMBL4434674 0.71 PDE10A (0.42) MAPK1
SCHEMBL8160434 0.71 TUBB1 (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed